BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22302465)

  • 41. The use of computerised glow curve analysis will optimise personal thermoluminescence dosimetry measurements. Opposing the proposition.
    Pradhan AS; Yoder RC
    Radiat Prot Dosimetry; 2002; 102(3):274-7. PubMed ID: 12430967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality audit of megavoltage radiotherapy units: intercomparison of dose at a reference point using a mailed TL-dosimetry system.
    Davis B; Faessler P
    Radiother Oncol; 1993 Jul; 28(1):79-81. PubMed ID: 8234874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mailed TL dosimetry programme for machine output check and clinical application in the EORTC radiotherapy group.
    Hansson U; Johansson KA; Horiot JC; Bernier J
    Radiother Oncol; 1993 Nov; 29(2):85-90. PubMed ID: 8310158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National and international standards and calibration of thermoluminescence dosimetry systems.
    Soares CG
    Radiat Prot Dosimetry; 2002; 101(1-4):167-71. PubMed ID: 12382728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postal dose audits for radiotherapy centers in Latin America and the Caribbean: trends in 1969-2003.
    Izewska J; Vatnitsky S; Shortt KR
    Rev Panam Salud Publica; 2006; 20(2-3):161-72. PubMed ID: 17199911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality control of radiotherapy centres in Europe: beam calibration.
    Dutreix A; Derreumaux S; Chavaudra J; van der Schueren E
    Radiother Oncol; 1994 Sep; 32(3):256-64. PubMed ID: 7816944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility study of entrance in vivo dose measurements with mailed thermoluminescence detectors.
    Swinnen A; Verstraete J; Huyskens DP
    Radiother Oncol; 2004 Oct; 73(1):89-96. PubMed ID: 15465151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishing IAEA TRS-457 diagnostic X-ray beam qualities at the Australian primary standard dosimetry laboratory.
    Lee KL; Butler D; Bailey T
    Australas Phys Eng Sci Med; 2017 Dec; 40(4):881-893. PubMed ID: 29159764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of regional radiotherapy dosimetry audit data and recommendations for future audits.
    Palmer A; Mzenda B; Kearton J; Wills R
    Br J Radiol; 2011 Aug; 84(1004):733-42. PubMed ID: 21159805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An analysis of the regulatory program of quality audits in radiotherapy in Brazil from 1995 to 2007.
    de Paiva E; da Rosa LA; Brito RR; de Sá LV; Dovales AC; Batista DV; Giannoni RA; Velasco AF
    J Appl Clin Med Phys; 2011 Jan; 12(2):3330. PubMed ID: 21587175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dosimetric inter-institutional comparison in European radiotherapy centres: Results of IAEA supported treatment planning system audit.
    Gershkevitsh E; Pesznyak C; Petrovic B; Grezdo J; Chelminski K; do Carmo Lopes M; Izewska J; Van Dyk J
    Acta Oncol; 2014 May; 53(5):628-36. PubMed ID: 24164104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative dosimetry study of three UK centres implementing total skin electron treatment through external audit.
    Misson-Yates S; Gonzalez R; McGovern M; Greener A
    Br J Radiol; 2015 May; 88(1049):20140723. PubMed ID: 25761213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency.
    Abdel-Wahab M; Rosenblatt E; Holmberg O; Meghzifene A
    J Am Coll Radiol; 2011 Nov; 8(11):789-94. PubMed ID: 22051464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scattered radiation from beam modifiers used with megavoltage therapy units.
    Scrimger J; Kolitsi Z
    Radiology; 1979 Jan; 130(1):233-6. PubMed ID: 103135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction factors kE and kQ for LiF-TLDs for dosimetry in megavoltage electron and photon beams.
    Bruggmoser G; Saum R; Saum F; Gainey M; Pychlau C; Kapsch RP; Zink K
    Z Med Phys; 2015 Jun; 25(2):186-91. PubMed ID: 24973310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of photoneutron intensities around radiotherapy linear accelerator 23-MV photon beam.
    Shweikani R; Anjak O
    Appl Radiat Isot; 2015 May; 99():168-71. PubMed ID: 25770858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality assurance in radiotherapy in Germany (as far as distinctions may occur compared to Britain).
    Rassow J
    Strahlenther Onkol; 1993 Mar; 169(3):179-86. PubMed ID: 8465253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IAEA/WHO postal dose audits for radiotherapy hospitals in Eastern and South-Eastern Europe.
    Izewska J; Vatnitsky S; Shortt KR
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S36-43. PubMed ID: 15679245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical dosimetry system for criticality accidents.
    Miljanić S; Ilijas B
    Radiat Prot Dosimetry; 2004; 110(1-4):477-81. PubMed ID: 15353694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo dosimetry with thermoluminescent dosimeters in external photon beam radiotherapy.
    Costa AM; Barbi GL; Bertucci EC; Ferreira H; Sansavino SZ; Colenci B; Caldas LV
    Appl Radiat Isot; 2010; 68(4-5):760-2. PubMed ID: 19819151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.